Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susan Stalter"'
Autor:
Roderich E. Schwarz, George Somlo, Timothy W. Synold, Bixin Xi, Yun Yen, Paul Frankel, Robert J. Morgan, James H. Doroshow, Warren Chow, Mariana Koczywas, Benjamin Paz, David Chu, Kim Margolin, Susan Stalter, Przemyslaw Twardowski, Lawrence D. Wagman, Lucille Leong, Merry Tetef, Stephen Shibata, Dean Lim, Paul Lin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(4)
Purpose: To determine the maximally tolerated dose, toxicity, and pharmacokinetics of i.p. gemcitabine. Experimental Design: Patients had peritoneal carcinomatosis. Gemcitabine (40, 80, 120, or 160 mg/m2) was administered into the peritoneal cavity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd8f6f5b3629b7758d15dee4eddb842
https://pubmed.ncbi.nlm.nih.gov/17317834
https://pubmed.ncbi.nlm.nih.gov/17317834
Autor:
Przemyslaw Twardowski, George Somlo, Warren Chow, Jeffrey Schriber, Neil Kogut, Susan Stalter, Lucille Leong, Yun Yen, James H. Doroshow, Mark McNamara, Paul Frankel, Robert J. Morgan, Kim Margolin, Joseph C. Alvarnas, Dean Lim, Stephen Shibata
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(11)
We evaluated the antitumor activity of tandem cycles of high-dose chemotherapy with autologous peripheral stem cell transplantation (aPSCT) in relapsed germ cell tumors by using high-dose paclitaxel, carboplatin, etoposide, and ifosfamide. Thirty-thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76efffd5a573468dc5f8ff8aaf386649
https://pubmed.ncbi.nlm.nih.gov/16275593
https://pubmed.ncbi.nlm.nih.gov/16275593
Autor:
Robert J, Morgan, James H, Doroshow, Timothy, Synold, Dean, Lim, Stephen, Shibata, Kim, Margolin, Roderich, Schwarz, Lucille, Leong, George, Somlo, Przemyslaw, Twardowski, Yun, Yen, Warren, Chow, Paul, Lin, Benjamin, Paz, David, Chu, Paul, Frankel, Susan, Stalter
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(16 Pt 1)
The purpose of this Phase I study was to determine the maximum tolerated dose and dose-limiting toxicities (DLTs) of i.p. docetaxel and to determine the peritoneal pharmacokinetics and pharmacological advantage of this agent.Twenty-one patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f83207ae51f23ffa09265e636b85d3a
https://pubmed.ncbi.nlm.nih.gov/14676112
https://pubmed.ncbi.nlm.nih.gov/14676112
Autor:
Gwendolyn Fyfe, Daniel C. Adelman, J. Gaudreault, Kim Margolin, Eric Holmgren, Michael S. Gordon, J. Breed, Susan Stalter, William Novotny
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(3)
PURPOSE: Tumor angiogenesis mediated by vascular endothelial growth factor (VEGF) is inhibited by the recombinant humanized (rhu) monoclonal antibody (MAb) rhuMAbVEGF, which has synergy with chemotherapy in animal models. The present study was design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec92fc9f8853be7f8ff68bad6daff7c8
https://pubmed.ncbi.nlm.nih.gov/11157039
https://pubmed.ncbi.nlm.nih.gov/11157039
Autor:
E. Holmgren, S. Shak, R. Benjamin, Susan Stalter, George W. Sledge, Michael S. Gordon, Kim Margolin, M. Talpaz, Daniel C. Adelman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(3)
PURPOSE: We investigated the safety and pharmacokinetics of a recombinant human monoclonal antibody to vascular endothelial growth factor (rhuMAb VEGF) in patients with cancer. PATIENTS AND METHODS: Cohorts of patients with metastatic cancer having f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c0924efe6917f47ba91bd78c409c1a
https://pubmed.ncbi.nlm.nih.gov/17470880
https://pubmed.ncbi.nlm.nih.gov/17470880
Publikováno v:
Business People. Jun2010, Vol. 23 Issue 5, p24-24. 1/9p.
Publikováno v:
Business People. Jun2010, Vol. 23 Issue 5, p21-24. 4p.
Autor:
David H. Ucko
Despite attracting headlines and hype, insurgents rarely win. Even when they claim territory and threaten governmental writ, they typically face a military backlash too powerful to withstand. States struggle with addressing the political roots of suc
Autor:
David H. Ucko
Despite attracting headlines and hype, insurgents rarely win. Even when they claim territory and threaten governmental writ, they typically face a military backlash too powerful to withstand. States struggle with addressing the political roots of suc